Michael E. Lewis

President at BioDiligence Partners, Inc.

72 year

Health Technology

Consumer Services

Profile

Michael E.
Lewis is the founder of Adolor Corp.
(1994), Cephalon, Inc. (1988), Arena Pharmaceuticals, Inc. (1997), and CARA Therapeutics, Inc. (2004).
He is currently a Director at PolyMedix Pharmaceuticals, Inc. (since 2002) and President at BioDiligence Partners, Inc. (since 1994).
He previously held positions as Director at Incara Pharmaceuticals Corp., Vice President-Research at Message Pharmaceuticals, Inc., Senior Director-Scientific Affairs at Cephalon, Inc., Director at Arena Pharmaceuticals, Inc., and Director & Chief Scientific Advisor at CARA Therapeutics, Inc. He also served as an Independent Director at PolyMedix, Inc. (2005-2013) and Aeolus Pharmaceuticals, Inc. (2011-2013).
Dr. Lewis received his undergraduate degree from George Washington University and his graduate and doctorate degrees from Clark University.

Michael E. Lewis active positions

Companies	Position	Start
PolyMedix Pharmaceuticals, Inc.	Director/Board Member	01/08/2002
BioDiligence Partners, Inc.	President	01/01/1994

All active positions of Michael E. Lewis

Former positions of Michael E. Lewis

Companies	Position	End
AEOLUS PHARMACEUTICALS, INC.	Director/Board Member	08/05/2013
POLYMEDIX, INC.	Director/Board Member	29/03/2013
Incara Pharmaceuticals Corp.	Director/Board Member	09/08/2004
ARENA PHARMACEUTICALS	Founder	01/01/2000
Adolor Corp. Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA.	Founder	-

See the detail of Michael E. Lewis's experience

Training of Michael E. Lewis

Clark University	Doctorate Degree
George Washington University	Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Michael E. Lewis's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	2
AEOLUS PHARMACEUTICALS, INC.	Health Technology
CARA THERAPEUTICS, INC.	Health Technology

Private companies	8
Incara Pharmaceuticals Corp.	Health Technology
PolyMedix, Inc. PolyMedix, Inc. Pharmaceuticals: MajorHealth Technology PolyMedix, Inc. engaged in developing first-in-class, small-molecule defensin-mimetics for the treatment of serious acute care conditions. The company was founded in 2002 and was headquartered in Radnor, PA.	Health Technology
PolyMedix Pharmaceuticals, Inc.
BioDiligence Partners, Inc.
Message Pharmaceuticals, Inc. Message Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Message Pharmaceuticals, Inc. develops pharmaceutical drugs. It operates as research development company involved in RNA research and exploring other types of RNAs to look for RNA-binding proteins, especially to combat RNA viruses and to treat all major disease categories. Message Pharmaceuticals was founded in 2002 and is located in Malvern, PA	Health Technology
Arena Pharmaceuticals, Inc. Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protein-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in Park City, UT.	Health Technology
Adolor Corp. Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA.	Health Technology
Cephalon, Inc. Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA.	Health Technology